This article was originally published in The Gray Sheet
Anticipates "mid-1999" debut of a "smaller, more portable" version of its Lasette laser finger perforator for professional blood glucose testing following FDA market clearance, announced Dec. 17. The firm gained 510(k) clearance for at-home consumer use of a larger version Dec. 7 ("The Gray Sheet" Dec. 14, p. 13)
You may also be interested in...
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.